Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,435 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07510737Recruiting
Cross training for frozen shoulder recovery
This study tests if adding cross-training exercises to standard physical therapy helps people with frozen shoulder move better and feel less pain. Cross-training means using the opposite arm to help the affected shoulder improve.
MalatyaAges 18–65 - NCT07514728Enrolling by invitation
Hyperbaric oxygen to slow breast cancer spread to lungs
This trial tests whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can slow the growth of breast cancer that has spread to the lungs. You would receive this treatment alongside standard care if your cancer has grown despite prior chemotherapy.
Jinan, ShandongAges 18–75 - NCT07514611Recruiting
Weight Loss Guidance for Heart Disease and Obesity
This trial tests whether using a smartphone app to guide weight loss helps people with coronary heart disease (a condition where blood vessels to the heart are narrowed) and obesity lose weight safely. The goal is to see if this personalized digital guidance can improve your health outcomes.
Guangzhou, GuangdongAges 18–65 - NCT07514208Enrolling by invitation
Headache Sensitivity and Pain Testing Study
This study examines how sensitive the skin and tissues around the head are in people with migraines or tension headaches. Researchers will perform gentle touch and pressure tests to understand pain patterns, which may help improve headache treatment in the future.
Barcelona, BarcelonaAges 18 years+ - NCT07515118Recruiting
Using AI to improve egg-stimulation timing for IVF
This study tests artificial intelligence to optimize when doctors trigger egg release during IVF treatment. Better timing may improve egg quality and IVF success rates. You'll have all ultrasound monitoring at the study center.
Sabadell, BarcelonaAges 18–42 - NCT07510308RecruitingPhase 1
Vaccine trial for advanced colorectal cancer
This trial tests a personalized vaccine made from your own tumor cells for advanced colorectal cancer that is mismatch repair proficient (pMMR). It aims to see if the vaccine can help when standard treatments have stopped working.
Chengdu, SichuanAges 18–75 - NCT07512102Recruiting
Eye Surgery Approach for Nearsightedness With Specific Eye Alignment
This study compares two different computer-guided surgical techniques for correcting nearsightedness using a laser eye procedure called SMILE. The research tests whether adjusting for your eye's natural alignment during surgery affects your vision results.
Guangzhou, GuangdongAges 18–40 - NCT07515326Recruiting
Physical Activity and Wellbeing Study for Breast Cancer Patients
This study follows women with breast cancer who are enrolled in KHEOPS, a physical activity program offered at Centre Léon Bérard. Researchers will track how the program affects your motivation, mood, and quality of life through weekly online surveys.
LyonAges 18 years+ - NCT07510334RecruitingPhase 2
VSV Virus Plus Immunotherapy for Advanced Kidney Cancer
This trial tests a combination of a special virus (VSV-IFNβ-NIS) with two immunotherapy drugs (ipilimumab and nivolumab) for people with advanced clear cell kidney cancer that hasn't been treated yet. It aims to see if this approach helps shrink tumors or slow the disease.
Rochester, MinnesotaAges 18 years+ - NCT07512089Recruiting
Blended Vision vs. Monovision LASIK for Reading Age
This study compares two laser eye surgery approaches for people over 40 who need reading glasses. Both methods use LASIK to reduce or eliminate your need for glasses, but they work differently—one eye may be set for distance and one for close-up (monovision), or both eyes may be adjusted for mixed vision (blended vision).
Guangzhou, GuangdongAges 40–55 - NCT06535308RecruitingPhase 1
Testing a new Alzheimer's drug for moderate disease
This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.
Seoul, Jongno-guAges 19–45 - NCT06625957RecruitingPhase 3
NTCB02-1 trial for patients needing IV nutrition
This trial tests an investigational IV nutrition product called NTCB02-1 in patients who need nutrition through a vein (parenteral nutrition) for at least 3 days. It aims to see if it is safe and works well.
Gyeonggi-do, Goyang-siAges 19 years+ - NCT06760910Recruiting
tDCS for older teens and adults with lazy eye
This study tests a gentle brain stimulation technique called transcranial direct current stimulation (tDCS) to see if it can help improve vision in older children and young adults with amblyopia (lazy eye).
Tianjin, Tianjin MunicipalityAges 10–30 - NCT06106893RecruitingPhase 1/Phase 2
Study of CD19 CAR-γδT cells for active lupus
This trial is testing a new type of immune cell therapy (called CD19 universal CAR-γδT cells) for people with active lupus that hasn't been well controlled by standard treatments. The goal is to see if these specially designed cells can calm the immune system and reduce lupus symptoms.
Wuhan, HubeiAges 18–70 - NCT06106906RecruitingPhase 1/Phase 2
CD19 CAR-T for Active Lupus
This study tests a new treatment called CD19 CAR-T, which reprograms your own immune cells to attack lupus. It is for people with active lupus that has not responded well to standard therapies.
Wuhan, HubeiAges 18–70 - NCT07500259Recruiting
Personalized drug testing for GI tumors
This trial uses a lab test to see how your tumor responds to different drugs, helping doctors choose the best treatment for you. It is for people with pancreatic cancer (PDAC) who are having surgery or a biopsy.
Luxembourg, LuxembourgAges 18 years+ - NCT07501559RecruitingPhase 1/Phase 2
Study of JL15003 for recurrent glioblastoma
This trial is testing a new drug (JL15003) given directly into the brain tumor using a small device called an Ommaya reservoir. It is for people whose glioblastoma has come back despite standard treatments. You will need to have had a polio vaccine booster before starting.
ShanghaiAges 18 years+ - NCT07505069RecruitingEarly Phase 1
PET imaging study for people with solid tumors
This trial is testing a new imaging agent called RT01-89Zr to see if it can help detect solid tumors during PET/CT scans. It involves an injection of the agent followed by imaging, and may offer a more targeted way to visualize tumors.
Wuxi, JiangsuAges 18–75 - NCT07500207Enrolling by invitationPhase 3
Rabies vaccine trial for people aged 10 to 60
This trial tests a new lyophilized rabies vaccine to see how well it works and how safe it is. It is for people who have not been vaccinated against rabies recently and have not been bitten or scratched by an animal that broke the skin in the past year.
Neijiang, SichuanAges 10–60 - NCT07499700RecruitingPhase 2/Phase 3
Study of BAT4406F injection for MCD and FSGS
This trial tests an injected drug called BAT4406F for people with Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS), two types of kidney diseases that cause swelling and high protein in urine. It aims to see if the drug can help patients who have responded well to steroid therapy in the past.
Beijing, Beijing MunicipalityAges 18–75 - NCT07501455Recruiting
Studying toothpaste and mouth rinse effects on gum inflammation
This study tests whether using a certain toothpaste and mouth rinse can reduce gum inflammation (gingivitis) better than brushing alone. It is for people with mild to moderate gum disease who have not used tobacco or certain medications recently.
Somerville, MassachusettsAges 18–60 - NCT07503028Enrolling by invitationEarly Phase 1
Stem cell therapy for severe low blood sugar in diabetes
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
Hefei, AnhuiAges 18–70 - NCT07499258Recruiting
Axonics R20 study for fecal incontinence
This trial is testing how well a device called Axonics R20 works for people with fecal incontinence. It may help if you have this condition and are willing to follow the study procedures.
New York, New YorkAges 18 years+ - NCT06643754RecruitingPhase 1/Phase 2
Study of a new drug (SHR-3276) for advanced cancers
This trial tests a new drug called SHR-3276 for people with advanced cancers that haven't responded to standard treatments. It aims to see if the drug is safe and works against tumors.
Chongqing, Chongqing MunicipalityAges 18–70
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,435 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.